🇺🇸 FDA
Patent

US 8071113

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 8071113 (Live, oral vaccine for protection against Shigella dysenteriae serotype 1) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K39/0283, A61K48/00